These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 27177506)

  • 1. Effective treatment with combination of peripheral 5-hydroxytryptamine synthetic inhibitor and 5-hydroxytryptamine 2 receptor antagonist on glucocorticoid-induced whole-body insulin resistance with hyperglycemia.
    Ma S; Li T; Guo K; Li X; An S; Hou S; Chen R; Yang B; Liu S; Fu J
    J Diabetes Investig; 2016 Nov; 7(6):833-844. PubMed ID: 27177506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Important role of 5-hydroxytryptamine in glucocorticoid-induced insulin resistance in liver and intra-abdominal adipose tissue of rats.
    Li T; Guo K; Qu W; Han Y; Wang S; Lin M; An S; Li X; Ma S; Wang T; Ji S; Hanson C; Fu J
    J Diabetes Investig; 2016 Jan; 7(1):32-41. PubMed ID: 26816599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term Stress with Hyperglucocorticoidemia-induced Hepatic Steatosis with VLDL Overproduction Is Dependent on both 5-HT2 Receptor and 5-HT Synthesis in Liver.
    Fu J; Ma S; Li X; An S; Li T; Guo K; Lin M; Qu W; Wang S; Dong X; Han X; Fu T; Huang X; Wang T; He S
    Int J Biol Sci; 2016; 12(2):219-34. PubMed ID: 26884719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-HT 2 receptor mediates high-fat diet-induced hepatic steatosis and very low density lipoprotein overproduction in rats.
    Li X; Guo K; Li T; Ma S; An S; Wang S; Di J; He S; Fu J
    Obes Res Clin Pract; 2018; 12(Suppl 2):16-28. PubMed ID: 27133527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic treatment of hydroxytryptamine type 2a receptor antagonist sarpogrelate hydrochloride modulates the vasoreactivity of serotonin in experimental rabbit vein grafts.
    Kodama A; Komori K; Kajikuri J; Itoh T
    J Vasc Surg; 2009 Sep; 50(3):617-25. PubMed ID: 19700096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Role of hyperglycemia-induced 5-hydroxytryptamine degradation of hepatic stellate cells in hepatic inflammation and fibrosis induced by type 2 diabetes mellitus].
    Liang XR; Shan XC; Guan J; Zhang R; Yang J; Zhang Y; Jin JQ; Zhang YX; Xu F; Fu JH
    Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Dec; 54(6):1141-1150. PubMed ID: 36533346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of sarpogrelate hydrochloride, a 5-HT2 blocker, on insulin resistance in Otsuka Long-Evans Tokushima fatty rats (OLETF rats), a type 2 diabetic rat model.
    Takishita E; Takahashi A; Harada N; Yamato M; Yoshizumi M; Nakaya Y
    J Cardiovasc Pharmacol; 2004 Feb; 43(2):266-70. PubMed ID: 14716215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serotonin potentiates high-glucose-induced endothelial injury: the role of serotonin and 5-HT(2A) receptors in promoting thrombosis in diabetes.
    Yamada K; Niki H; Nagai H; Nishikawa M; Nakagawa H
    J Pharmacol Sci; 2012; 119(3):243-50. PubMed ID: 22785018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-HT2 receptor blockade exhibits 5-HT vasodilator effects via nitric oxide, prostacyclin and ATP-sensitive potassium channels in rat renal vasculature.
    García-Pedraza JA; García M; Martín ML; Rodríguez-Barbero A; Morán A
    Vascul Pharmacol; 2016 Apr; 79():51-59. PubMed ID: 26586311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibiting serotonin signaling through HTR2B in visceral adipose tissue improves obesity-related insulin resistance.
    Choi WG; Choi W; Oh TJ; Cha HN; Hwang I; Lee YK; Lee SY; Shin H; Lim A; Ryu D; Suh JM; Park SY; Choi SH; Kim H
    J Clin Invest; 2021 Dec; 131(23):. PubMed ID: 34618686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-fat diet and glucocorticoid treatment cause hyperglycemia associated with adiponectin receptor alterations.
    de Oliveira C; de Mattos AB; Biz C; Oyama LM; Ribeiro EB; do Nascimento CM
    Lipids Health Dis; 2011 Jan; 10():11. PubMed ID: 21244702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blockade of 5-HT
    Hernández-Abreu OI; García-Pedraza JÁ; Rivera-Mancilla E; Villanueva-Castillo B; Morán A; García-Domingo M; Manrique-Maldonado G; Altamirano-Espinoza AH; Villalón CM
    Clin Exp Pharmacol Physiol; 2020 Mar; 47(3):403-411. PubMed ID: 31846086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of the binding sites and selectivity of sarpogrelate, a novel 5-HT2 antagonist, to human 5-HT2A, 5-HT2B and 5-HT2C receptor subtypes by molecular modeling.
    Rashid M; Manivet P; Nishio H; Pratuangdejkul J; Rajab M; Ishiguro M; Launay JM; Nagatomo T
    Life Sci; 2003 May; 73(2):193-207. PubMed ID: 12738034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic 5-HT
    García-Pedraza JÁ; Hernández-Abreu O; García M; Morán A; Villalón CM
    Can J Physiol Pharmacol; 2018 Apr; 96(4):328-336. PubMed ID: 28886249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic sarpogrelate treatment improves renal sympathetic hyperactivity in experimental diabetes.
    Fernández-González JF; García-Pedraza JÁ; Terol-Úbeda AC; Martín ML; Morán A; García-Domingo M
    Biomed Pharmacother; 2024 Jul; 176():116814. PubMed ID: 38820974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adipose tissue compensates for defect of phosphatidylinositol 3'-kinase induced in liver and muscle by dietary fish oil in fed rats.
    Corporeau C; Foll CL; Taouis M; Gouygou JP; Bergé JP; Delarue J
    Am J Physiol Endocrinol Metab; 2006 Jan; 290(1):E78-E86. PubMed ID: 16339925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic activity of sarpogrelate and dopamine D
    Fouad Shalaby MA; Abd El Latif HA; El Yamani M; Galal MA; Kamal S; Sindi I; Masaood R
    BMC Pharmacol Toxicol; 2021 Oct; 22(1):64. PubMed ID: 34702339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of sarpogrelate on altered STZ-diabetes induced cardiovascular responses to 5-hydroxytryptamine in rats.
    Umrani DN; Bodiwala DN; Goyal RK
    Mol Cell Biochem; 2003 Jul; 249(1-2):53-7. PubMed ID: 12956398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotonin receptor antagonist inhibits monocrotaline-induced pulmonary hypertension and prolongs survival in rats.
    Hironaka E; Hongo M; Sakai A; Mawatari E; Terasawa F; Okumura N; Yamazaki A; Ushiyama Y; Yazaki Y; Kinoshita O
    Cardiovasc Res; 2003 Dec; 60(3):692-9. PubMed ID: 14659815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperglycemia induced by the 5-HT receptor agonist, 5-methoxytryptamine, in rats: involvement of the peripheral 5-HT2A receptor.
    Yamada J; Sugimoto Y; Yoshikawa T; Horisaka K
    Eur J Pharmacol; 1997 Apr; 323(2-3):235-40. PubMed ID: 9128844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.